ArticleCureus2025
Monitoring Hematologic Parameters in Pediatric Oncology Patients Diagnosed With Sepsis or Febrile Neutropenia: A Tertiary Center Experience.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study analyzes hematologic and inflammatory parameters in pediatric oncology patients with febrile neutropenia (FN) or sepsis, aiming to identify simple diagnostic markers. Conducted in a tertiary center, 150 infectious episodes were evaluated. Results showed statistically significant differences in leukocyte (G1: 4.95-7.03, p=0.01/G2: 4.91-7.01, p=0.01) and neutrophil counts (G1: 3.10-4.05, p=003/G2: 3.22-5.70, p=0.02) after treatment, especially in sepsis cases, with a statistically significant decrease in C-reactive protein (p=0.01) and procalcitonin (p=0.01) post-therapy. Although fibrinogen showed limited diagnostic value, the observed variation may still reflect a relevant pattern, as suggested in prior research. These findings highlight the importance of accessible biomarkers in guiding early diagnosis and management in resource-limited healthcare settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.